APA (7th ed.) Citation

T, L., A, M., L, T., K, P., & O, B. (2026). Novel therapies in myeloid neoplasms show limited benefit and increased costs over 15 years of follow-up in Southern Finland. Annals of hematology, 105(3), 94. https://doi.org/10.1007/s00277-026-06863-y

Chicago Style (17th ed.) Citation

T, Lanamtieng, Mervaala-Muroke A, Toivanen L, Porkka K, and Brück O. "Novel Therapies in Myeloid Neoplasms Show Limited Benefit and Increased Costs over 15 Years of Follow-up in Southern Finland." Annals of Hematology 105, no. 3 (2026): 94. https://doi.org/10.1007/s00277-026-06863-y.

MLA (9th ed.) Citation

T, Lanamtieng, et al. "Novel Therapies in Myeloid Neoplasms Show Limited Benefit and Increased Costs over 15 Years of Follow-up in Southern Finland." Annals of Hematology, vol. 105, no. 3, 2026, p. 94, https://doi.org/10.1007/s00277-026-06863-y.